PRODUCT DETAIL

Tolupind 40 mg/1,5 mg tablety s riadeným uvoľňovaním

Code

8970E

MA number

58/0047/25-S

Product Form:

tbl mod 10x40 mg/1,5 mg (blis.OPA/Al/PVC//Al)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Decentralised

MAH, country:

KRKA, d.d., Novo mesto, Slovenia

Therapeutic Class:

58 - HYPOTENSIVA

ATC:

C	CARDIOVASCULAR SYSTEM
C09	AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09D	ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
C09DA	Angiotensin II antagonists and diuretics
C09DA07	TELMISARTAN AND DIURETICS

Shelf life:

Container:

blister OPA/Al/PVC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10b fixed combination application
MA issued:	07.02.2025
Validity:	07.02.2030
PIL:	PIL_Tolupind 40 mg_1,5 mg; 80 mg_1,5 mg tablety s riadeným uvoľňovaním_02.2025.pdf
SPC:	SPC_Tolupind 40 mg_1,5 mg; 80 mg_1,5 mg tablety s riadeným uvoľňovaním_02.2025.pdf
Safety feature	Yes
Data update:	13.02.2025